As filed with the Securities and Exchange Commission on April 1, 2019
Registration No. 333-176268
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 2
TO
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
OCEAN BIO-CHEM, INC.
(Exact name of Registrant as specified in its charter)
| Florida | 59-1564329 | |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
| 4041 SW 47 Avenue, Ft. Lauderdale, FL | 33314 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Ocean Bio-Chem, Inc. 2008 Non-Qualified Stock Option Plan
(Full title of the plan)
Peter G. Dornau
Chairman of the Board, President and Chief Executive Officer
Ocean Bio-Chem, Inc.
4041 SW 47 Avenue
Ft. Lauderdale, FL 33314
954-587-6280
(Name, address and telephone number, including area code, of agent for service)
with a copy to:
Alan Singer
Morgan, Lewis & Bockius LLP
1701 Market Street
Philadelphia, PA 19103-2921
215-963-5000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents, filed by Ocean Bio-Chem., Inc. (the “Registrant”) with the Securities and Exchange Commission (the “Commission”), are hereby incorporated by reference:
| (a) | Annual Report on Form 10-K for the fiscal year ended December 31, 2018; |
| (b) | The description of the Registrant’s common stock set forth in its Registration Statement filed under the Securities Exchange Act of 1934, including any amendment or report filed for the purpose of updating such description. |
All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934 after the date of this registration statement and prior to the filing of a post-effective amendment to the registration statement that indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this registration statement and to be a part hereof from the date of filing of such documents.
Any statement contained in a document incorporated or deemed to be incorporated by reference or deemed to be part of this registration statement shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained in this registration statement or in any other subsequently filed document that also is, or is deemed to be, incorporated by reference or deemed to be part of this registration statement modifies or replaces such statement. Any statement contained in a document that is deemed to be incorporated by reference or deemed to be part of this registration statement after the most recent effective date may modify or replace existing statements contained in this registration statement. Any such statement so modified or replaced shall not be deemed, except as so modified or replaced, to constitute a part of this registration statement.
Experts
The audited consolidated financial statements of the Registrant as of December 31, 2018 and for the year then ended, and the audited adjustments to retrospectively apply the change in accounting for revenue from contracts with customers in the audited consolidated financial statements of the Registrant as of December 31, 2017 and for the year then ended as described in paragraph 3 of Note 1 to such financial statements, incorporated in this Registration Statement by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018, have been so incorporated in reliance on the report of Accell Audit and Compliance, P.A., an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.
In the event that Accell Audit and Compliance, P.A. consents to the incorporation by reference in this registration statement of its report relating to audited financial statements included in a document subsequently filed by the Registrant, such audited financial statements shall be incorporated herein in reliance upon such report of Accell Audit and Compliance, P.A., an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.
The consolidated balance sheets of Ocean Bio-Chem, Inc. as of December 31, 2017, and the related consolidated statements of operations, shareholders’ equity, and cash flows for year ended December 31, 2017, before the effects of adjustments to retrospectively apply the change in accounting for revenue from contracts with customers as described in paragraph 3 of Note 1 to such financial statements, have been audited by EisnerAmper LLP, independent registered public accounting firm, as stated in their report which is incorporated by reference. Such financial statements have been incorporated by reference in reliance on the report of such firm given upon their authority as experts in accounting and auditing.
1
Item 8. Exhibits.
The file number for each of the Registrant’s filings with the Securities and Exchange Commission referenced below is 0-11102.
*Previously filed
2
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this post-effective amendment to the registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Ft. Lauderdale, State of Florida on April 1, 2019.
| OCEAN BIO-CHEM, INC. | ||
| By: | /s/ PETER G. DORNAU | |
| Peter G. Dornau | ||
| President and Chief Executive Officer | ||
Pursuant to the requirements of the Securities Act of 1933, this post-effective amendment to the registration statement has been signed by the following persons in the capacities and on the dates indicated.
| Signature | Capacity | Date | ||
| /s/ JEFFREY S. BAROCAS | ||||
| Jeffrey S. Barocas | Chief Financial Officer and Director | April 1, 2019 | ||
| (Principal Financial and Accounting Officer) | ||||
| * | ||||
| Diana Mazuelos Conard | Director | April 1, 2019 | ||
| * | ||||
| Gregor M. Dornau | Director | April 1, 2019 | ||
| /s/ PETER G. DORNAU | ||||
| Peter G. Dornau | Chief Executive Officer and Director | April 1, 2019 | ||
| * | ||||
| William W. Dudman | Director | April 1, 2019 | ||
| Kimberly A. Krause | Director | |||
| * | ||||
| James M. Kolisch | Director | April 1, 2019 | ||
| * | ||||
| John B. Turner | Director | April 1, 2019 |
|
*By |
/s/ JEFFREY S. BAROCAS | |
| Jeffrey S. Barocas | ||
| Attorney-in-Fact |
3